Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Insmed Inc (NASDAQ: INSM) closed at $75.16 down -0.95% from its previous closing price of $75.88. In other words, the price has decreased by -$0.95 from its previous closing price. On the day, 0.72 million shares were traded. INSM stock price reached its highest trading level at $76.53 during the session, while it also had its lowest trading level at $74.83.
Ratios:
For a deeper understanding of Insmed Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 2.41 whereas as Long-Term Debt/Eq ratio is at 2.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on April 23, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $55 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 13 ’24 when Smith Michael Alexander sold 27,871 shares for $74.35 per share. The transaction valued at 2,072,223 led to the insider holds 67,856 shares of the business.
Flammer Martina M.D. sold 26,969 shares of INSM for $2,019,978 on Sep 13 ’24. The Chief Medical Officer now owns 106,134 shares after completing the transaction at $74.90 per share. On Sep 16 ’24, another insider, Flammer Martina M.D., who serves as the Chief Medical Officer of the company, sold 13,436 shares for $74.92 each. As a result, the insider received 1,006,625 and left with 106,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 13575174144 and an Enterprise Value of 13138337792. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.83 while its Price-to-Book (P/B) ratio in mrq is 27.81. Its current Enterprise Value per Revenue stands at 38.309 whereas that against EBITDA is -18.903.
Stock Price History:
Over the past 52 weeks, INSM has reached a high of $80.53, while it has fallen to a 52-week low of $21.92. The 50-Day Moving Average of the stock is 4.13%, while the 200-Day Moving Average is calculated to be 35.53%.
Shares Statistics:
For the past three months, INSM has traded an average of 1.54M shares per day and 1683220 over the past ten days. A total of 178.90M shares are outstanding, with a floating share count of 174.44M. Insiders hold about 2.50% of the company’s shares, while institutions hold 105.22% stake in the company. Shares short for INSM as of 1731628800 were 12100491 with a Short Ratio of 7.88, compared to 1728950400 on 13696809. Therefore, it implies a Short% of Shares Outstanding of 12100491 and a Short% of Float of 6.8500000000000005.
